Serge Jard

Psychology · Social Sciences

49h-index7.2kcitations163works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine regulation and behavior(91), Electrolyte and hormonal disorders(49), Receptor Mechanisms and Signaling(28), Circadian rhythm and melatonin(20), Neuropeptides and Animal Physiology(17)

Publications163 total

Adenylate cyclase from synchronized neuroblastoma cells: Responsiveness to prostaglandin E1, adenosine, and dopamine during the cell cycle (cell synchronization/adenylate cyclase sensitivity)
2016
Vasopressin Receptors
Frontiers of hormone research·2015· 36 cited
The Vasopressin-Sensitive Adenylate Cyclase from the Mammalian Kidney
2015· 5 cited
Anounncement / Erratum
Neuroendocrinology·2008Open Access
Functional Architecture of Vasopressin/Oxytocin Receptors
Journal of Receptors and Signal Transduction·1999· 35 cited
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus
Journal of the American Society of Nephrology·1998· 114 cited
Vasopressin receptors. A historical survey.
PubMed·1998· 49 cited
Vasopressin Receptors
Advances in experimental medicine and biology·1998· 48 cited
Mapping Peptide-binding Domains of the Human V1a Vasopressin Receptor with a Photoactivatable Linear Peptide Antagonist
Journal of Biological Chemistry·1997· 59 citedOpen Access
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors
European Journal of Pharmacology·1997· 23 citedOpen Access
Identification of a Single Residue Responsible for Agonist Selectivity in the Oxytocin‐Vasopressin Receptors
Annals of the New York Academy of Sciences·1997· 5 cited
Étude fonctionnelle de mutations du gène du récepteur V2 responsables d'un diabète insipide néphrogénique congénital
Archives de Pédiatrie·1997
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Journal of Clinical Investigation·1996· 247 citedOpen Access
Étude fonctionnelle de deux mutations du gène du RV2, responsables d'un diabète insipide néphrogénique lié à l'X
Archives de Pédiatrie·1996
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin
FEBS Letters·1996· 109 citedOpen Access
Three-dimensional structure of G protein-coupled receptors: from speculations to facts
Pharmacochemistry library·1996· 1 cited
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Journal of Biological Chemistry·1995· 265 citedOpen Access
Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation.
Proceedings of the National Academy of Sciences·1995· 66 citedOpen Access
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
The EMBO Journal·1995· 180 citedOpen Access
Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors
Pharmacological Research·1995· 1 cited
page 1 of 9Next →

Frequent Co-authors

Claude Barberis(15), Gilles Guillon(8), Rabary M. Rajerison(7), Bernard Mouillac(5), Jack Elands(5), Joël Bockaert(5), Daniel Butlen(5), Marcel Hibert(4), Eliane Tribollet(4), Christian Roy(4), M N Balestre(4), Jacky Marie(3), M. Manning(3), Bice Chini(3), Marie‐Noëlle Balestre(3), Susanne Trumpp-Kallmeyer(3), Jan Hoflack(3), B. Cantau(3), Sylvie Audigier(3), François M. M. Morel(3)